The North American respiratory device market was valued at around $6.6 billion in 2018 and is estimated to grow at a CAGR of around 6.2% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in North America. The increasing demand from COPD, Sleep Apnea and asthma patients in the US for the respiratory device and favorable reimbursement in the US is favoring the growth of the regional market. North American respiratory device is further analyzed into the US and Canada. The US is the major market due to greater healthcare expenditure and a higher prevalence rate of respiratory diseases.